Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Carbohydrate Research|July 15, 1988
Blood group Tn-active macromolecules from human carcinomas and erythrocytes: characterization of and specific reactivity with mono- and poly-clonal anti-Tn antibodies induced by various immunogensG F Springer, E V Chandrasekaran, P R Desai, et al.Immunological Communications|January 1, 1975
Effect of carbamylation of lysine epsilon-amino groups on the activity of blood group specific glycoproteinsG F Springer, H J Yang, P R Desai, et al.Journal of Surgical Oncology|January 1, 1979
Human carcinoma-associated precursor antigens of the NM blood group systemG F Springer, P R Desai, M S Murthy, et al.Journal of Immunological Methods|December 27, 1995
Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detectionP R Desai, L H Ujjainwala, S C Carlstedt, et al.Cancer|June 15, 1980
Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigenG F Springer, M S Murthy, P R Desai, et al.Klinische Wochenschrift|September 17, 1979
Delayed-type skin hypersensitivity reaction (DTH) to Thomsen-Friedenreich (T) antigen as diagnostic test for human breast adenocarcinomaG F Springer, P R Desai, M S Murthy, et al.Cancer Biotherapy|January 1, 1994
T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinomaG F Springer, P R Desai, H Tegtmeyer, et al.The Journal of Surgical Research|October 1, 1983
Delayed-type cutaneous hypersensitivity to Thomsen-Friedenreich (T) antigen in patients with pancreatic cancerR L Goodale, G F Springer, J G Shearen, et al.Clinical Immunology and Immunopathology|November 1, 1988
Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigensD M Thomson, G F Springer, P R Desai, et al.Cancer Detection and Prevention|January 1, 1995
T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinomaG F Springer, P R Desai, B D Spencer, et al.Pageof 6